Strong prevalence of cardiovascular diseases, increasing awareness, and growing demand for cardiac health diagnostic & monitoring devices are the primary factors contributing towards the demand and growth of the global electrophysiology devices market. The electrophysiology devices are used in detecting and monitoring the presence and location of abnormal rhythm with the help of low voltage electric pulses.
The irregularities in the rhythm arises due to scarring of heart post heart attacks, high blood pressure and ageing. This has fueled the demand for electrophysiological devices and cardiac catheterization techniques. The burden of cardiac diseases has increased significantly over last two decades due to sedentary lifestyle coupled with increased alcohol consumption, smoking, and consumption of processed food. The abnormal heart rhythm can lead to sudden cardiac arrest leading to cardiac failure. Consequently, the demand for devices to monitor cardiac rhythm has increased significantly. The electrophysiology devices market is expected to grow significantly during the forecast period.
North America contributed the largest share to the global electrophysiology devices market in 2019 and is anticipated to be a dominating geography during the forecast period owing to the presence of leading device manufacturers, high prevalence of cardiovascular diseases, and increasing investment on development of advanced products. Additionally, early adoption of advanced modalities is anticipated to contribute towards the growth of North America electrophysiology devices market in coming years. Asia Pacific is anticipated to be the fastest growing segment during the forecast period owing to increasing investment in healthcare infrastructure, rising incidences of cardiovascular diseases, and adoption of advanced medical devices across the major economies.
The report titled “Electrophysiology Devices Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global electrophysiology devices market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Medtronic plc reported revenues of USD 30,557 million in 2019 and the product segment analysis of the company indicates that Cardiac & Vascular Group business segment of the company dominated revenue in 2019.
The global electrophysiology devices market is segmented based on product type, application, end use, and geography. Based on product type, the global electrophysiology devices market is segmented into diagnostic devices and treatment devices. The diagnostic devices are sub-segmented into Holter monitoring devices, diagnostic electrophysiology catheters, electrocardiograph (ECG), EP mapping & imaging systems, insertable cardiac monitors (ICM), and others. The treatment devices are sub-segmented into implantable cardioverter defibrillators (ICDs), automated external defibrillators (AEDs), pacemakers, CRT-P, CRT-D, catheters, and others. Based on application, the global electrophysiology devices market is segmented into atrial fibrillation (AF), supraventricular tachycardia, atrioventricular nodal re-entry tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), bradycardia, and other. Based on end use, the global electrophysiology devices market is segmented into hospitals, ambulatory surgical centers, and others. Based on geography, the global electrophysiology devices market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on electrophysiology devices. Further, market share of prominent companies in the global electrophysiology devices market would also be estimated. For instance, Medtronic plc operates through four business segments namely Cardiac & Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The electrophysiology devices products are delivered under Cardiac & Vascular Group business segment of the company with revenue contribution of US$ 11,505 million in 2019.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the Electrophysiology Devices companies. The global electrophysiology devices market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the electrophysiology devices business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global electrophysiology devices market.
Major players active in the global electrophysiology devices market include Abbott Laboratories, Biosense Webster, Inc. (a Johnson & Johnson Company), Biotronik SE & Co.KG, Boston Scientific Corporation, GE Healthcare, Koninklijke Philips N.V., Medtronic plc, Microport Scientific Corporation, Siemens AG, and St. Jude Medical, Inc.
Market Segmentation:
By Type
- Treatment devices
- Implantable Cardioverter Defibrillators (ICDs)
- Automated external defibrillators (AEDs)
- Pacemakers
- CRT-P
- CRT-D
- Catheters
- Others
- Diagnostic devices
- Holter Monitoring Devices
- Diagnostic Electrophysiology Catheters
- Electrocardiograph (ECG)
- EP Mapping & Imaging Systems
- Implantable cardiac monitors (ICM)
- Others
By Indication
- Atrial Fibrillation (AF)
- Supraventricular Tachycardia
- Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
- Wolff-Parkinson-White Syndrome (WPW)
- Bradycardia
- Others
By End Use
- Hospitals
- Ambulatory Surgical Centers
- Others
By Geography:
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Rest of South America
